Basics |
Company: |
bioAffinity Technologies, Inc. |
IPO Date: |
September 1, 2022 |
Sector: |
Healthcare |
Industry: |
Diagnostics and Research |
Market Cap: |
$12.94M |
Activated in VL: |
True |
Average Daily Range |
Avg Daily Range: |
$0.10 | 4.67%
|
Avg Daily Range (30 D): |
$0.03 | 3.89%
|
Avg Daily Range (90 D): |
$0.05 | 4.41%
|
Institutional Daily Volume |
Avg Daily Volume: |
.39M |
Avg Daily Volume (30 D): |
.15M |
Avg Daily Volume (90 D): |
.14M |
Trade Size |
Avg Trade Size (Sh.): |
222 |
Avg Trade Size (Sh.) (30 D): |
331 |
Avg Trade Size (Sh.) (90 D): |
313 |
Institutional Trades |
Total Inst.Trades: |
9 |
Avg Inst. Trade: |
$1.46M |
Avg Inst. Trade (30 D): |
$.56M |
Avg Inst. Trade (90 D): |
$.56M |
Avg Inst. Trade Volume: |
.13M |
Avg Inst. Trades (Per Day): |
3 |
Market Closing Trades |
Avg Closing Trade: |
$M |
Avg Closing Trade (30 D): |
$M |
Avg Closing Trade (90 D): |
$M |
Avg Closing Volume: |
K |
|
|
|
|
Financials |
|
TTM |
Q3 2024 |
Q2 2024 |
Basic EPS
|
$-.8
|
$-.16
|
$-.19
|
Diluted EPS
|
$-.8
|
$-.16
|
$-.19
|
Revenue
|
$ 9.42M
|
$ 2.35M
|
$ 2.4M
|
Gross Profit
|
$
|
$
|
$
|
Net Income / Loss
|
$ 8.77M
|
$ -2M
|
$ -2.11M
|
Operating Income / Loss
|
$ -8.35M
|
$ -1.97M
|
$ -2.09M
|
Cost of Revenue
|
$
|
$
|
$
|
Net Cash Flow
|
$ -3.75M
|
$ -.04M
|
$ -1.65M
|
PE Ratio
|
|
|
|
|